Raphael is a Research Associate in the Health Economics Unit, currently working alongside Dr Raymond Oppong on the CURLY trial. The clinical study aims to determine the optimal duration of oral cefalexin therapy for children with febrile urinary tract infections.
Previously, Raphael completed a BSc in Biomedical Science at Bangor University and worked in a pharmacy. These experiences shaped his interest in antimicrobial resistance, which he explored further through his MSc Health Economics and Health Policy dissertation project at the University of Birmingham. His long-term ambition is to pursue a PhD investigating antimicrobial resistance interventions and their implications for health equity.